CMS is moving forward with its proposals to address unlawful payment reductions to 340B drug reimbursement, according to a final rule released November 2. The final rule keeps most of the provisions of the proposed rule intact with only a few adjustments based on commenter feedback.Read More »
Hospitals need to start preparing for major changes to price transparency requirements, according to the 2024 Outpatient Prospective Payment System (OPPS) final rule, released November 2. The final rule details a slew of changes to price transparency compliance along with reimbursement changes...Read More »
The conversion factor cuts that CMS floated earlier in the year are now confirmed—and heightened. Part B providers will have to prepare for a net 3.4% payment decrease across services in 2024, according to the 2024 Medicare Physician Fee...Read More »
HHS released a proposed rule on October 27 regarding the federal independent dispute resolution (IDR) process for the No Surprises Act. The rule focuses on early communication between payers and providers, the open negotiation period, batching, eligibility, administrative fee structure, and...Read More »
The Office of Inspector General (OIG) recently conducted an audit to determine the financial impacts of expanding CMS’ hospital transfer policy for discharges to post-acute care to include all MS-DRGs.Read More »
Pharmacy revenue generally is a top revenue driver at most organizations, but too often it’s treated similarly to other service lines within the organization that don’t have nearly the same charging complexities and nuances nor the impact to the bottom line...Read More »
The complete 2023 NAHRI Leadership Council Research Series has been released. Based on our research survey on revenue cycle automation, the Council hosted two roundtable discussions of the results and produced three reports. The first half of the results are analyzed in the...Read More »
CMS recently updated the national payment allowance and provided billing instructions for the new Novavax COVID-19 vaccine, authorized for patients 12 years and older.Read More »
